These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1945005)

  • 1. [Amikacin in the treatment of genito-urinary an pulmonary infections in oncologic patients].
    Citerio P
    Minerva Med; 1991 Sep; 82(9):565-8. PubMed ID: 1945005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycoplasmas as agents of human disease.
    Cassell GH; Cole BC
    N Engl J Med; 1981 Jan; 304(2):80-9. PubMed ID: 6777700
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of combination therapy with cefoxitin and amikacin in complicated urinary tract infections].
    Sakashita S; Shinno Y; Asano Y; Tubo S; Imanaka K; Miyabe N; Nagamori S; Takahashi Y; Koyanagi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1547-50. PubMed ID: 3565192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ureaplasma urealyticum urogenital infections and assessment of antibiotic resistance].
    De Leo C; Somma MC; Gaido J; Fusco A
    Minerva Ginecol; 2000 Dec; 52(12 Suppl 1):120-2. PubMed ID: 11526680
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on Chlamydia trachomatis as a cause of lower urogenital tract infection.
    Johannisson G
    Acta Derm Venereol Suppl (Stockh); 1981; 93():1-55. PubMed ID: 6945025
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenic role of Chlamydia in urogenital infections].
    Møller BR; Mårdh PA
    Nord Med; 1980 Apr; 95(4):128-32. PubMed ID: 7367249
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the efficacy of isepamicin in the adult core clinical trial programme.
    Carbon C
    J Chemother; 1995 Jun; 7 Suppl 2():79-85. PubMed ID: 8622115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isepamicin versus amikacin in the treatment of urinary tract infection.
    Sturm W
    J Chemother; 1995 Jun; 7 Suppl 2():149-54. PubMed ID: 8622104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-shot vs conventional therapy with amikacin for treatment of uncomplicated urinary tract infections: a multicenter study.
    Rocca Rossetti S
    Chemioterapia; 1986 Dec; 5(6):394-9. PubMed ID: 3802301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of ampicillin in the therapy of infections of the biliary tract and of the urogenital system].
    Biasin G; Formenton D; Pelà L
    Chir Ital; 1967 Apr; 19(2):201-9. PubMed ID: 5188953
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
    Petrikkos G; Giamarellou H; Tsagaraki C; Pefanis A
    J Chemother; 1995 Jun; 7 Suppl 2():161-4. PubMed ID: 8622106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of ciprofloxacin therapy in urinary and respiratory tract infections].
    Polubiec A; Jórasz I; Kłos K; Ozarek-Medyńska T; Pietrzak J; Starzyńska R; Stepka K
    Pol Tyg Lek; 1990 Jan 22-29; 45(4-5):85-9. PubMed ID: 2395758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the local use of amikacin].
    Wada S; Nishio S; Kishimoto T; Maekawa M; Yuki K; Sasaki S; Oshima N; Hayahara N; Nishijima T; Funai K
    Hinyokika Kiyo; 1985 May; 31(5):907-13. PubMed ID: 4050636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring treatment with amikacin for urinary tract infections].
    Pieloch Z; Kowalczyk L; Adamska-Dyniewska H
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):478-80. PubMed ID: 8170815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of first-line ceftriaxone and amikacin in the treatment of severe urinary tract infections in the adult].
    Lepage JY; Juge C; Cozian A; Espaze E; Reynaud AE; Souron R; Baron D
    Pathol Biol (Paris); 1987 May; 35(5):638-41. PubMed ID: 3302875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New drugs: Amikacin].
    Hofstetter A
    Urologe A; 1976 Sep; 15(5):258-9. PubMed ID: 973282
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recognition of the problem and significance of genitourinary leptotrichosis].
    Berić B; Durdević J; Nikolin D
    Jugosl Ginekol Opstet; 1984; 24(1-2):15-7. PubMed ID: 6503327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.